{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:26:24Z","timestamp":1791516384171,"version":"4.3.4"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.seizure.2017.06.022","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T14:46:13Z","timestamp":1498574773000},"page":"173-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Outside the box: Medications worth considering when traditional antiepileptic drugs have failed"],"prefix":"10.1016","volume":"50","author":[{"given":"Adrian L.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Scott","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.06.022_bib0005","first-page":"1907","article-title":"Luminal bei epilepsie","volume":"59","author":"Hauptmann","year":"1912","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"10.1016\/j.seizure.2017.06.022_bib0010","first-page":"435","article-title":"Propri\u00e9t\u00e9s pharmacodynamiques de l\u2019acide n-dipropylac\u00e9tique: ler M\u00e9moire: Prori\u00e9t\u00e9s anti\u00e9pileptiques","volume":"18","author":"Meunier","year":"1963","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.seizure.2017.06.022_bib0015","unstructured":"Acetazolamide. Schaumburg (IL): Sagent Pharmaceuticals, Inc., 2013 Feb. Package insert. NDC 25021-817-10."},{"key":"10.1016\/j.seizure.2017.06.022_bib0020","series-title":"Epilepsy and the functional anatomy of the human brain","author":"Penfield","year":"1954"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1528-1167.2010.02722.x","article-title":"Age- and region specific effects of anticonvulsants and bumetanide on 4-aminopyridine-induced seizure-like events in immature rat hippocampal-entorhinal cortex slices","volume":"52","author":"Wahab","year":"2011","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2017.06.022_bib0030","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1523\/JNEUROSCI.3836-13.2014","article-title":"Intracellular bicarbonate regulates action potential generation via KCNQ channel modulation","volume":"34","author":"Jones","year":"2014","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1535-7597.2002.00018.x","article-title":"Diuretics as antiepileptic drugs: should we go with the flow?","volume":"2","author":"Staley","year":"2002","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2017.06.022_bib0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuropharm.2015.04.015","article-title":"Carbonic anhydrase inhibition by acetazolamide reduces in vitro epileptiform synchronization","volume":"95","author":"Hamidi","year":"2015","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.seizure.2017.06.022_bib0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/13543776.2013.782394","article-title":"Anticonvulsant\/antiepileptic carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Aggarwal","year":"2013","journal-title":"Expert Opin Ther Pat"},{"issue":"4968","key":"10.1016\/j.seizure.2017.06.022_bib0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/bmj.1.4968.650","article-title":"Acetazolamide in treatment of epilepsy","volume":"24","author":"Ansell","year":"1956","journal-title":"Br Med J"},{"issue":"s44","key":"10.1016\/j.seizure.2017.06.022_bib0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1469-8749.1981.tb02064.x","article-title":"Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children","volume":"23","author":"Forsythe","year":"1981","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1528-1157.1989.tb05285.x","article-title":"Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures","volume":"30","author":"Oles","year":"1989","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.seizure.2012.12.003","article-title":"A case of atypical benign partial epilepsy with action myoclonus","volume":"22","author":"Kobayashi","year":"2013","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1528-1157.1989.tb05456.x","article-title":"Mechanisms of tolerance to the anticonvulsant effects of acetazolamide in mice: relation to the activity and amount of carbonic anhydrase in brain","volume":"30","author":"Anderson","year":"1989","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/106002809603000515","article-title":"Acetazolamide in the treatment of seizures","volume":"30","author":"Reiss","year":"1996","journal-title":"Ann Pharmacother."},{"issue":"6","key":"10.1016\/j.seizure.2017.06.022_bib0080","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/epi.12125","article-title":"Risk factors for hyperammonemia in pediatric patients with epilepsy","volume":"54","author":"Yamamoto","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0085","first-page":"38","article-title":"The use of amantadine in Parkinson\u2019s disease and other akinetic-rigid disorders","volume":"4","author":"Warren","year":"2004","journal-title":"Adv Clin Neurosci Rehab"},{"key":"10.1016\/j.seizure.2017.06.022_bib0090","unstructured":"Amantadine hydrochloride (Symmetrel\u00ae) [Internet]. Chadds Ford(PA): Endo Pharmaceuticals, Inc.; 2009 Jan [cited 2017, February 4]. Package insert. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/016023s041,018101s016lbl.pdf."},{"key":"10.1016\/j.seizure.2017.06.022_bib0095","unstructured":"Amantadine hydrochloride. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/FBB1F2\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/B744D6\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=amantadine&UserSearchTerm=amantadine&SearchFilter=filterNone&navitem=searchALL#."},{"issue":"7","key":"10.1016\/j.seizure.2017.06.022_bib0100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.174.4007.408","article-title":"Dopamine: release from the brain in vivo by amantadine","volume":"174","author":"Von Voigtlander","year":"1971","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.seizure.2017.06.022_bib0105","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00702-002-0694-7","article-title":"New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: a PET [(11)C]raclopride study","volume":"109","author":"Moresco","year":"2002","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0028-3908(88)90043-3","article-title":"Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures","volume":"27","author":"Warter","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2017.06.022_bib0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0920-1211(98)00053-9","article-title":"The role of basal ganglia in the control in the control of generalized absence seizures","volume":"32","author":"Deransart","year":"1998","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0920-1211(96)00015-0","article-title":"Thalamic NMDA transmission in a genetic model of absence epilepsy in rats","volume":"25","author":"Koerner","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.06.022_bib0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0022-3476(05)81922-5","article-title":"Effect of add-on amantadine therapy for refractory absence epilepsy","volume":"121","author":"Shahar","year":"1992","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0922-4106(91)90113-V","article-title":"Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study","volume":"206","author":"Kornhuber","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jnr.23500","article-title":"N-methyl-D-aspartate receptor channel blockers prevent pentylenetretrazole-induced convulsions and morphological changes in rat brain neurons","volume":"93","author":"Zaitsev","year":"2015","journal-title":"J Neurosci Res."},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1212\/WNL.35.4.579","article-title":"Amantadine in the treatment of refractory epilepsy in childhood: an open trial in 10 patients","volume":"35","author":"Shields","year":"1985","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1980.tb04303.x","article-title":"Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice","volume":"21","author":"Kleinrok","year":"1980","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2012.02.004","article-title":"Amantadine for the treatment of refractory absence seizures in children","volume":"46","author":"Perry","year":"2012","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.seizure.2017.06.022_bib0155","unstructured":"Bumetanide (Bumex\u00ae) [Internet]. Parsippany(NJ):Validus Pharmaceuticals, LLC.; 2008 [cited 2017, February 4]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/018225s024lbl.pdf."},{"issue":"January (1)","key":"10.1016\/j.seizure.2017.06.022_bib0160","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1152\/ajprenal.00119.2002","article-title":"Loop diuretics: from the Na-K-2Cl transporter to clinical use","volume":"284","author":"Shankar","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"18","key":"10.1016\/j.seizure.2017.06.022_bib0165","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1074\/jbc.273.18.11295","article-title":"Comparison of Na-K-Cl cotransporters NKCC1, NKCC2, and the HEK cell Na-L-Cl cotransporter","volume":"273","author":"Isenrig","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/physrev.2000.80.1.211","article-title":"Sodium-potassium-chloride cotransport","volume":"80","author":"Russell","year":"2000","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1570159X13666150205130359","article-title":"Expanding spectrum of sodium potassium chloride co-transporters in the pathophysiology of diseases","volume":"13","author":"Jaggi","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0180","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1523\/JNEUROSCI.1421-05.2006","article-title":"The chloride transporter Na(+)-K(+)-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia","volume":"26","author":"Pond","year":"2006","journal-title":"J Neurosci."},{"key":"10.1016\/j.seizure.2017.06.022_bib0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1744-8069-3-17","article-title":"Spinal KNCC1 blockade inhibits TRPV1-dependent referred allodynia","volume":"3","author":"Pitcher","year":"2007","journal-title":"Mol Pain."},{"key":"10.1016\/j.seizure.2017.06.022_bib0190","doi-asserted-by":"crossref","first-page":"e35417","DOI":"10.1371\/journal.pone.0035417","article-title":"Loop diuretics have anxiolytic effects in rat models of conditioned anxiety","volume":"7","author":"Krystal","year":"2012","journal-title":"Plos One."},{"issue":"6","key":"10.1016\/j.seizure.2017.06.022_bib0195","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/epi.12620","article-title":"Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures","volume":"55","author":"Puskarjov","year":"2014","journal-title":"Epilepsia"},{"issue":"35","key":"10.1016\/j.seizure.2017.06.022_bib0200","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1523\/JNEUROSCI.1769-10.2010","article-title":"Progressive KNCC1-dependent neuronal chloride accumulation during neonatal seizures","volume":"30","author":"Dzhala","year":"2010","journal-title":"J Neurosci."},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1528-1167.2010.02722.x","article-title":"Age- and region-specific effects of anticonvulsants and bumetanide on 4-aminopyridine-induced seizure-like events in immature rat hippocampal-entorhinal cortex slices","volume":"52","author":"Wahab","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.06.022_bib0210","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1146\/annurev.physiol.64.081501.155847","article-title":"Human and murine phenotypes associated with defects in cation-chloride cotransport","volume":"64","author":"Delpire","year":"2002","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0215","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations","volume":"87","author":"Ben-Ari","year":"2007","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0220","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/j.1528-1167.2012.03654.x","article-title":"Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy","volume":"54","author":"Eftekhari","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0225","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0883073809333526","article-title":"Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(\u2212) cotransporter NKCC1","volume":"24","author":"Kahle","year":"2009","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.21229","article-title":"Bumetanide enhances phenobarbital efficacy in neonatal seizure model","volume":"63","author":"Dzhala","year":"2008","journal-title":"Ann Neurol"},{"issue":"pt. 4","key":"10.1016\/j.seizure.2017.06.022_bib0235","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/brain\/awr041","article-title":"Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital","volume":"134","author":"Nardou","year":"2011","journal-title":"Brain"},{"issue":"25","key":"10.1016\/j.seizure.2017.06.022_bib0240","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2017.06.022_bib0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fncel.2016.00090","article-title":"Failure of the NEMO trial: bumetanide is a promising agent to treat many brain disorders but not newborn seizures","volume":"10","author":"Ben-Ari","year":"2016","journal-title":"Front Cell Neurosci."},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/ther.2012.0013","article-title":"Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and SCN1A mutation: a case report","volume":"2","author":"Shein","year":"2012","journal-title":"Ther Hypothermia Temp Manage."},{"issue":"January 11","key":"10.1016\/j.seizure.2017.06.022_bib0260","article-title":"Depolarizing GABA contributes to glutamatergic network rewiring in epilepsy","author":"Kourdougli","year":"2017","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0265","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/epi.13270","article-title":"Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus","volume":"57","author":"Sivakumaran","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.06.022_bib0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yebeh.2016.03.021","article-title":"The search for NKCC1-selective drugs for the treatment of epilepsy: structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A","volume":"59","author":"Lykke","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2017.06.022_bib0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2014.11.019","article-title":"The organic anion transport inhibitor probenecid increase brain concentrations of the NCKK1 inhibitor bumetanide","volume":"746","author":"T\u00f6llner","year":"2015","journal-title":"Eur J Pharmacol."},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0280","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.24124","article-title":"A novel prodrug-based strategy to increase effects of bumetanide in epilepsy","volume":"75","author":"T\u00f6llner","year":"2014","journal-title":"Ann Neurol."},{"key":"10.1016\/j.seizure.2017.06.022_bib0285","unstructured":"Imipramine hydrochloride. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/903F9A\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/86DEEC\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=Imipramine+Hydrochloride&fromInterSaltBase=true&false=null&false=null&=null#."},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12272-015-0676-6","article-title":"Differential effects of sodium channel blockers on in vitro induced epileptiform activities","volume":"40","author":"Gall","year":"2017","journal-title":"Arch Pharm Res"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0295","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.30.2.126","article-title":"Antiabsence drugs and inhibitory pathways","volume":"30","author":"Fromm","year":"1980","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0887-8994(86)90033-0","article-title":"The use of imipramine in minor motor seizures","volume":"2","author":"Hurst","year":"1986","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0305","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1124\/mol.62.5.1228","article-title":"Inhibition of Na+ current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker","volume":"62","author":"Yang","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00431733","article-title":"Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms","volume":"51","author":"Trimble","year":"1977","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.seizure.2017.06.022_bib0315","first-page":"631","article-title":"Pharmacological modulation of central monoaminergic systems and influence on the anticonvulsant effectiveness of standard antiepileptics in minimal electroshock seizure","volume":"47","author":"Fischer","year":"1988","journal-title":"Biomed Biochim Acta"},{"issue":"6","key":"10.1016\/j.seizure.2017.06.022_bib0320","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2008.02.006","article-title":"Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamics measure of combined antidepressant-anticonvulsant action","volume":"54","author":"Smolders","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0325","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneur.1972.00490150006002","article-title":"Imipramine in epilepsy","volume":"27","author":"Fromm","year":"1972","journal-title":"Arch Neurol."},{"issue":"9 Pt. 1","key":"10.1016\/j.seizure.2017.06.022_bib0330","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/WNL.28.9.953","article-title":"Imipramine in absence and myoclonic-astatic seizures","volume":"28","author":"Fromm","year":"1978","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0335","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0387-7604(95)00040-I","article-title":"Reduction of seizure frequency with clomipramine in patients with complex partial seizures","volume":"17","author":"Sakakihara","year":"1995","journal-title":"Brain Dev"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0340","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1176\/ajp.132.5.538","article-title":"Imipramine and seizures","volume":"132","author":"Petti","year":"1975","journal-title":"Am J Psychiatry."},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1528-1157.1976.tb03396.x","article-title":"Biphasic effects of imipramine in experimental models of epilepsy","volume":"17","author":"Lange","year":"1976","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2017.06.022_bib0350","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.yebeh.2004.07.012","article-title":"Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality","volume":"5","author":"Mac\u00eado","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2006.06.022","article-title":"Mechanism of imipramine-induced seizures in amygdala-kindled rats","volume":"72","author":"Ago","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.06.022_bib0360","unstructured":"Lidocaine hydrochloride. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/0E1DD9\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/163559\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=Lidocaine+Hydrochloride&fromInterSaltBase=true&false=null&false=null&=null#."},{"key":"10.1016\/j.seizure.2017.06.022_bib0365","unstructured":"Lidocaine hydrochloride. Schaumburg (IL): APP Pharmaceuticals, LLC.; 2008 Apr. Package insert. NDC: 63323-208-05."},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0370","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000542-197104000-00010","article-title":"The effects of lidocaine on inhibition in the cerebral cortex","volume":"34","author":"Warnick","year":"1971","journal-title":"Anesthesiology"},{"issue":"3 Pt. 2","key":"10.1016\/j.seizure.2017.06.022_bib0375","first-page":"R582","article-title":"Blood-brain barrier transport and brain sequestration of propranolol and lidocaine","volume":"247","author":"Pardridge","year":"1984","journal-title":"Am J Physiol."},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0380","first-page":"31","article-title":"A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures","volume":"17","author":"Tulloch","year":"2012","journal-title":"J Pediatr Pharmacol Ther."},{"key":"10.1016\/j.seizure.2017.06.022_bib0385","series-title":"Jasper's Basic Mechanisms of the Epilepsies [Internet]","article-title":"Neonatal seizures and neuronal transmembrane ion transport","author":"Kahle","year":"2012"},{"key":"10.1016\/j.seizure.2017.06.022_bib0390","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1651-2227.1988.tb10602.x","article-title":"Lidocaine for treatment of severe seizures in newborn infants","volume":"77","author":"Hellstr\u00f6m-Westas","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.seizure.2017.06.022_bib0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1651-2227.1992.tb12075.x","article-title":"Lidocaine for treatment of severe seizures in newborn infants: II. blood concentrations of lidocaine and metabolites during intravenous infusion","volume":"81","author":"Hellstr\u00f6m-Westas","year":"1992","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0400","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1528-1157.2002.25301.x","article-title":"Lidocaine-dependent early infantile status epilepticus with highly suppressed EEG","volume":"43","author":"Sawaishi","year":"2002","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0405","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1684\/epd.2013.0593","article-title":"Successful treatment of early myoclonic encephalopathy using lidocaine and carbamazepine","volume":"15","author":"Nakano","year":"2013","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2017.06.022_bib0410","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00431-006-0136-x","article-title":"Development of an optimal lidocaine infusion strategy for neonatal seizures","volume":"165","author":"Malingr\u00e9","year":"2006","journal-title":"Eur J Pediatr"},{"issue":"7","key":"10.1016\/j.seizure.2017.06.022_bib0415","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/11589160-000000000-00000","article-title":"Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures","volume":"50","author":"van den Broek","year":"2011","journal-title":"Clin Phamacokinet"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0420","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/epi.13286","article-title":"Lidocaine response rate in aEEG-confirmed neonatal seizures: retrospective study of 413 full-term and preterm infants","volume":"57","author":"Weeke","year":"2016","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2017.06.022_bib0425","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/apa.12311","article-title":"Efficacy and safety of lidocaine for treatment of neonatal seizures","volume":"102","author":"Lundqvist","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.seizure.2017.06.022_bib0430","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/archneurpsyc.1955.02330140092017","article-title":"A new treatment of status epilepticus \u2212intravenous injection of local anesthetic","volume":"74","author":"Bernhard","year":"1955","journal-title":"Arch Neurol Psychiatry"},{"issue":"9","key":"10.1016\/j.seizure.2017.06.022_bib0435","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1553-2712.1997.tb03820.x","article-title":"Lidocaine in the treatment of status epilepticus","volume":"4","author":"Walker","year":"1997","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0440","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1017\/S0012162206000466","article-title":"Intravenous lidocaine for status epilepticus during childhood","volume":"48","author":"Hamano","year":"2006","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0445","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/088307380201700520","article-title":"Neonatal mydriasis: intravenous lidocaine adverse reaction","volume":"17","author":"Berger","year":"2002","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0450","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000430767","article-title":"Lidocaine-associated cardiac events in newborns with seizures: incidence, symptoms, and contributing factors","volume":"108","author":"Weeke","year":"2015","journal-title":"Neonatology"},{"issue":"May","key":"10.1016\/j.seizure.2017.06.022_bib0455","article-title":"Psychiatric and behavioural disorders in children with epilepsy (ILAE task force report): epilepsy and ADHD","author":"Besag","year":"2016","journal-title":"Epileptic Disord"},{"issue":"May 19","key":"10.1016\/j.seizure.2017.06.022_bib0460","article-title":"Psychiatric and behavioural disorders in children with epilepsy (ILAE task force report): behavioural and psychiatric disorders associated with childhood epilepsy syndromes","author":"Besag","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2017.06.022_bib0465","unstructured":"Amphetamine. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/5AEA53\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/AAC87E\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.IntermediateToDocumentLink?docId=931622&contentSetId=100&title=Amphetamine&servicesTitle=Amphetamine&topicId=null#."},{"key":"10.1016\/j.seizure.2017.06.022_bib0470","unstructured":"Dextroamphetamine sulfate. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/13B09B\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/3AB855\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=dextroamphetamine&UserSearchTerm=dextroamphetamine&SearchFilter=filterNone&navitem=searchGlobal#."},{"key":"10.1016\/j.seizure.2017.06.022_bib0475","unstructured":"Lisdexamphetamine dimesylate. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/5A5FD2\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/8C7034\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=Lisdexamfetamine&UserSearchTerm=Lisdexamfetamine&SearchFilter=filterNone&navitem=searchGlobal#."},{"key":"10.1016\/j.seizure.2017.06.022_bib0480","unstructured":"Methamphetamine. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/BA6E26\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/0793B3\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=methamphetamine&UserSearchTerm=methamphetamine&SearchFilter=filterNone&navitem=searchGlobal#."},{"key":"10.1016\/j.seizure.2017.06.022_bib0485","unstructured":"Methylphenidate hydrochloride. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/2897D8\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/C5FE10\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=Methylphenidate+Hydrochloride&fromInterSaltBase=true&false=null&false=null&=null#."},{"key":"10.1016\/j.seizure.2017.06.022_bib0490","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2014.04.026","article-title":"Comparing stimulant effects in youth with ADHD symptoms and epilepsy","volume":"36","author":"Gonzalez-Heydrich","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0495","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0887-8994(00)00240-X","article-title":"Stimulant therapy and seizure risk in children with ADHD","volume":"24","author":"Hemmer","year":"2001","journal-title":"Pediatr Neurol"},{"issue":"March (3)","key":"10.1016\/j.seizure.2017.06.022_bib0500","first-page":"248","article-title":"Methamphetamine sulfate in the treatment of nocturnal epileptic seizures","volume":"42","author":"Logothetis","year":"1959","journal-title":"Minn Med"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0505","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jama.1975.03260030068033","article-title":"Dextroamphetamine for epilepsy","volume":"233","author":"Livingston","year":"1975","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.seizure.2017.06.022_bib0510","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1528-1157.1990.tb05518.x","article-title":"Landau-Kleffner syndrome: a pharmacologic study of five cases","volume":"31","author":"Marescaux","year":"1990","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0515","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/08830738030180020601","article-title":"Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities","volume":"18","author":"Gucuyener","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2017.06.022_bib0520","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yebeh.2015.02.019","article-title":"Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies","volume":"46","author":"Radziuk","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0525","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0920-1211(96)00012-5","article-title":"Parent-completed scales for measuring seizure severity and severity of side-effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis","volume":"24","author":"Carpay","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.06.022_bib0530","unstructured":"Verapamil hydrochloride (Calan \u00ae). New York (NY): G.D. Searle, LLC.; 2009 Apr. Package insert."},{"key":"10.1016\/j.seizure.2017.06.022_bib0535","unstructured":"Verapamil hydrochloride. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, February 4]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/EBC4D1\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/46FB58\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=verapamil&UserSearchTerm=verapamil&SearchFilter=filterNone&navitem=searchALL#."},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0540","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0006-8993(81)91271-3","article-title":"Stimulation induced changes in extracellular free calcium in normal cortex and chronic alumina cream foci of cats","volume":"213","author":"Heinemann","year":"1981","journal-title":"Brain Res"},{"issue":"4620","key":"10.1016\/j.seizure.2017.06.022_bib0545","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.6623068","article-title":"Fast extracellular calcium transients: involvement in epileptic processes","volume":"222","author":"Pumain","year":"1983","journal-title":"Science"},{"issue":"6069","key":"10.1016\/j.seizure.2017.06.022_bib0550","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/321519a0","article-title":"NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones","volume":"321","author":"MacDermott","year":"1986","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0555","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(86)90592-6","article-title":"Laminar profiles of the changes in extracellular calcium concentration induced by repetitive stimulation and excitatory amino acids in the rat dentate gyrus","volume":"69","author":"Mody","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.seizure.2017.06.022_bib0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(96)00576-8","article-title":"Simultaneous blockade of intracellular increases of neuronal epileptiform depolarizations by verapamil","volume":"734","author":"Wiemann","year":"1996","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0565","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1526-4610.2008.01298.x","article-title":"Verapamil for cluster headache: clinical pharmacology and possible mode of action","volume":"49","author":"Tfelt-Hansen","year":"2009","journal-title":"Headache"},{"issue":"Pt 1","key":"10.1016\/j.seizure.2017.06.022_bib0570","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/brain\/awf002","article-title":"Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy","volume":"125","author":"Sisodiya","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.seizure.2017.06.022_bib0575","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.0013-9580.2005.31904.x","article-title":"Potential role of drug transporters in the pathogenesis of medically intractable epilepsy","volume":"46","author":"Kwan","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0580","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"L\u00f6scher","year":"2005","journal-title":"NeuroRx"},{"issue":"6","key":"10.1016\/j.seizure.2017.06.022_bib0585","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.seizure.2017.06.022_bib0590","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1046\/j.1528-1157.2001.01901.x","article-title":"In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats","volume":"42","author":"Potschka","year":"2001","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2017.06.022_bib0595","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiements in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci Lett."},{"issue":"15","key":"10.1016\/j.seizure.2017.06.022_bib0600","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0605","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737175.2016.1121097","article-title":"The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy","volume":"16","author":"Nicita","year":"2016","journal-title":"Expert Rev Neurother."},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0610","first-page":"521","article-title":"Anticonvulsant effects of calcium channel blockers in partial and generalized model epilepsies","volume":"1","author":"Speckmann","year":"1986","journal-title":"Funct Neurol."},{"issue":"5","key":"10.1016\/j.seizure.2017.06.022_bib0615","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0028-3908(88)90126-8","article-title":"Effect of various calcium channel blockers on three different models of limbic seizures in rats","volume":"27","author":"Vezzani","year":"1988","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0620","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0013-4694(85)91096-X","article-title":"Suppression of focal epileptiform discharges by intraventricular perfusion of a calcium antagonist","volume":"61","author":"Walden","year":"1985","journal-title":"Electroencephalogr Clin Neurophysiol."},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0625","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0013-4694(88)90006-5","article-title":"Suppression of recurrent generalized tonic-clonic seizure discharges by intraventricular perfusion of a calcium antagonist","volume":"69","author":"Walden","year":"1988","journal-title":"Electroencephalogr Clin Neurophysiol."},{"issue":"10","key":"10.1016\/j.seizure.2017.06.022_bib0630","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1345\/aph.1E068","article-title":"Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy","volume":"38","author":"Summers","year":"2004","journal-title":"Ann Pharmacother."},{"issue":"4","key":"10.1016\/j.seizure.2017.06.022_bib0635","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.yebeh.2010.01.166","article-title":"Verapamil attenuates the malignant treatment course in recurrent status epilepticus","volume":"17","author":"Schmitt","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"12","key":"10.1016\/j.seizure.2017.06.022_bib0640","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1111\/j.1468-1331.2011.03513.x","article-title":"Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil","volume":"18","author":"Pirker","year":"2011","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0645","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yebeh.2013.07.006","article-title":"Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: a pilot study","volume":"29","author":"Asadi-Pooya","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2017.06.022_bib0650","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.eplepsyres.2016.07.004","article-title":"Low dose verapamil as an adjunct therapy for medically refractory epilepsy \u2013 an open label pilot study","volume":"126","author":"Narayanan","year":"2016","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2009.02.014","article-title":"Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy","volume":"85","author":"Iannetti","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.06.022_bib0660","first-page":"S141","article-title":"Verapamil as adjunctive therapy for seizures in Dravet Syndrome","volume":"74","author":"Wical","year":"2013","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1016\/j.seizure.2017.06.022_bib0665","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2013.09.009","article-title":"Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: a pilot study","volume":"23","author":"Nicita","year":"2014","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.seizure.2017.06.022_bib0670","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.eplepsyres.2014.08.009","article-title":"A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures","volume":"108","author":"Bortlot","year":"2014","journal-title":"Epilepsy Res"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0675.1","doi-asserted-by":"crossref","unstructured":"Lexicomp Online\u00ae. Acetazolamide. [updated 2017, June 16","DOI":"10.1007\/s40278-017-28098-9"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0675.2","unstructured":"cited 2017, June 18]. In: Lexi-Drugs\u00ae. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6274."},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0680.1","unstructured":"Lexicomp Online\u00ae. Amantadine. [updated 2017, May 26"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0680.2","unstructured":"cited 2017 Jun 18]. In: Lexi-Drugs\u00ae. Hudson, OH : Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6319."},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0685.1","unstructured":"Lexicomp Online\u00ae. Bumetanide. [updated 2017, June 9"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0685.2","unstructured":"cited 2017 Jun 18]. In: Lexi-Drugs\u00ae. Hudson, OH : Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6480."},{"key":"10.1016\/j.seizure.2017.06.022_bib0690","unstructured":"Bumetanide. Micromedex \u00ae [Internet]. Greenwood Village (CO): Truven Health Analytics. 1974\u20132017 [cited 2017, June 18]. Available from: http:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/PFDefaultActionId\/evidencexpert.DoIntegratedSearch#."},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0695.1","unstructured":"Lexicomp Online\u00ae. Imipramine. [updated 2017, May 31"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0695.2","unstructured":"cited 2017, June 18]. In: Lexi-Drugs\u00ae. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/7075."},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0700.1","unstructured":"Lexicomp Online\u00ae. Lidocaine. [updated 2017, June 9"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0700.2","unstructured":"cited 2017, June 18]. In: Lexi-Drugs\u00ae. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/1797832."},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0705.1","unstructured":"Lexicomp Online\u00ae. Amphetamine and Dextroamphetamine. [updated 2017, March 21"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0705.2","unstructured":"cited 2017, June 18]. In: Lexi-Drugs\u00ae. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6721."},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0710.1","unstructured":"Lexicomp Online\u00ae. Methylphenidate. [updated 2017, June 2"},{"key":"#cr-split#-10.1016\/j.seizure.2017.06.022_bib0710.2","unstructured":"cited 2017 Jun 18]. In: Lexi-Drugs\u00ae. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/7281."},{"key":"10.1016\/j.seizure.2017.06.022_bib0715","unstructured":"Lexicomp Online\u00ae. Verapamil. [updated 2017, June 2016; cited 2017, June 18]. In: Lexi-Drugs\u00ae. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc. c2017. Available from: http:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/7863."}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:49:47Z","timestamp":1761011387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117301851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":150,"alternative-id":["S1059131117301851"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.06.022","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outside the box: Medications worth considering when traditional antiepileptic drugs have failed","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}